Literature DB >> 10647120

Involvement of CD4+ T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice.

T Tachibana1, T Matsuyama, M Mitsuyama.   

Abstract

The cell-mediated immune response against infection with Sporothrix schenckii was investigated in vivo and in vitro. Following primary infection, mice were protected against a secondary subcutaneous inoculation with S. schenckii as determined by the local growth of fungi, and subcutaneously immunized mice were able to survive a lethal intravenous infection. Protection could be transferred to naive congenitally athymic nude mice using lymph node cells taken from immune mice. When immune lymph node cells had CD4+ cells depleted by antibody plus complement, the ability to transfer protection was significantly reduced. Treatment of mice with carrageenan, a macrophage blocker, before and after secondary inoculation abolished protection. An in vitro system, using either immune lymph node cells alone or macrophages alone, failed to kill the organism. However, inhibition of fungal growth was observed when both immune lymph node cells and macrophages were combined. Growth inhibition in vitro was reduced after depletion of CD4+ cells but not CD8+ cells. Addition of anti-interferon (IFN)-gamma monoclonal antibodies (MAb) also reduced growth inhibition. By using reverse transcription-polymerase chain reaction (RT-PCR) analysis, it was shown that immune lymph node cells expressed message for IFN-gamma, tumour necrosis factor (TNF)-alpha and interleukin (IL)-10 after stimulation with heat-killed S. schenckii. These results suggest that acquired immunity against S. schenckii is expressed mainly by macrophages activated by CD4+ T cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10647120     DOI: 10.1046/j.1365-280x.1999.00239.x

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  19 in total

1.  Adenosine deaminase activity in serum and lymphocytes of rats infected with Sporothrix schenckii.

Authors:  Verônica S P Castro; Victor C Pimentel; Aleksandro S Da Silva; Gustavo R Thomé; Patrícia Wolkmer; Jorge L C Castro; Márcio M Costa; Cássia B da Silva; Daniele C Oliveira; Sydney H Alves; Maria R C Schetinger; Sonia T A Lopes; Cinthia M Mazzanti
Journal:  Mycopathologia       Date:  2011-12-15       Impact factor: 2.574

Review 2.  Sporothrix schenckii and Sporotrichosis.

Authors:  Mônica Bastos de Lima Barros; Rodrigo de Almeida Paes; Armando Oliveira Schubach
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

3.  Virulence of Sporothrix schenckii conidia and yeast cells, and their susceptibility to nitric oxide.

Authors:  K S Fernandes; A L Coelho; L M Lopes Bezerra; C Barja-Fidalgo
Journal:  Immunology       Date:  2000-12       Impact factor: 7.397

4.  Impaired host defense against Sporothrix schenckii in mice with chronic granulomatous disease.

Authors:  Hideko Kajiwara; Mitsumasa Saito; Shouichi Ohga; Takeshi Uenotsuchi; Shin-ichi Yoshida
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

5.  Detrimental role of endogenous nitric oxide in host defence against Sporothrix schenckii.

Authors:  Karla Simone S Fernandes; Edward Helal Neto; Marcelly M S Brito; João S Silva; Fernando Q Cunha; Christina Barja-Fidalgo
Journal:  Immunology       Date:  2008-01-09       Impact factor: 7.397

Review 6.  Molecular Components of the Sporothrix schenckii Complex that Induce Immune Response.

Authors:  Carlos A Alba-Fierro; Armando Pérez-Torres; Conchita Toriello; Yolanda Romo-Lozano; Everardo López-Romero; Estela Ruiz-Baca
Journal:  Curr Microbiol       Date:  2016-04-27       Impact factor: 2.188

Review 7.  Current research on the immune response to experimental sporotrichosis.

Authors:  Iracilda Zeppone Carlos; Micheli Fernanda Sassá; Diana Bridon da Graça Sgarbi; Marisa Campos Polesi Placeres; Danielle Cardoso Geraldo Maia
Journal:  Mycopathologia       Date:  2009-02-25       Impact factor: 2.574

8.  Therapeutic monoclonal antibody for sporotrichosis.

Authors:  Sandro R Almeida
Journal:  Front Microbiol       Date:  2012-11-28       Impact factor: 5.640

9.  Taenia taeniaeformis in rat favors protracted skin lesions caused by Sporothrix schenckii infection: Dectin-1 and IL-17 are dispensable for clearance of this fungus.

Authors:  Xiaohui Zhang; Jing Zhang; Huaiqiu Huang; Ruzeng Xue; Xuchu Hu; Meirong Li; Yi Zhong; Liyan Yuan
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

10.  Sporotrichosis: an emerging neglected opportunistic infection in HIV-infected patients in Rio de Janeiro, Brazil.

Authors:  Dayvison Francis Saraiva Freitas; Antonio Carlos Francesconi do Valle; Margarete Bernardo Tavares da Silva; Dayse Pereira Campos; Marcelo Rosandiski Lyra; Rogerio Valls de Souza; Valdiléa Gonçalves Veloso; Rosely Maria Zancopé-Oliveira; Francisco Inácio Bastos; Maria Clara Gutierrez Galhardo
Journal:  PLoS Negl Trop Dis       Date:  2014-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.